Cargando…
Clinical Perspectives on Targeting Therapies for Personalized Medicine
Expected benefits from new technology include more efficient patient selection for clinical trials, more cost-effective treatment pathways for patients and health services and a more profitable accelerated approach for drug developers. Regulatory authorities expect the pharmaceutical and biotechnolo...
Autores principales: | Singer, Donald R.J., Zaïr, Zoulikha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102676/ https://www.ncbi.nlm.nih.gov/pubmed/26827603 http://dx.doi.org/10.1016/bs.apcsb.2015.11.003 |
Ejemplares similares
-
Personalized medicine-molecular targeted cancer therapy
por: Osamura, Robert Y, et al.
Publicado: (2009) -
The clastogenicity of 4NQO is cell-type dependent and linked to cytotoxicity, length of exposure and p53 proficiency
por: Brüsehafer, Katja, et al.
Publicado: (2016) -
An economic perspective on personalized medicine
por: Jakka, Sairamesh, et al.
Publicado: (2013) -
Personalized medicine: risk prediction, targeted therapies and mobile health technology
por: Hayes, Daniel F, et al.
Publicado: (2014) -
Policy perspectives on the emerging pathways of personalized medicine
por: Downing, Gregory J.
Publicado: (2009)